0001103021-20-000125.txt : 20200811 0001103021-20-000125.hdr.sgml : 20200811 20200811165310 ACCESSION NUMBER: 0001103021-20-000125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200807 FILED AS OF DATE: 20200811 DATE AS OF CHANGE: 20200811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Jeffrey Allen CENTRAL INDEX KEY: 0001500210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 201093106 MAIL ADDRESS: STREET 1: KING PHARMACEUTICALS, INC. STREET 2: 501 FIFTH STREET CITY: BRISTOL STATE: TN ZIP: 37620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_159717917539790.xml FORM 4 X0306 4 2020-08-07 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001500210 Bailey Jeffrey Allen 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 1 1 0 0 Chief Executive Officer Common Stock 2020-08-07 4 M 0 5567 0 A 5567 D Restricted Stock Units 0.0 2020-08-07 4 M 0 5567 0 D 2021-08-06 Common Stock 5567.0 5567 D The restricted stock units ("RSUs") were issued to the Reporting Person on July 30, 2020, as compensation for service on the Issuer's board of directors. The remaining RSUs will vest in the first open window following the Company's 2021 Annual Meeting of Stockholders. Jeffrey A Bailey 2020-08-11